Rigorous, defensible email-spoofability verdict and SPF supply-chain risk analysis computed from published DNS alone. Deepens the record-level SPF/DMARC/DKIM/BIMI/MTA-STS/DNSSEC fetch recipes in the offensive-osint arsenal (§16.14) with the reasoning that section doesn't do: a priority-ordered composite verdict for whether an attacker can actually land header-From-spoofed mail in an inbox, and by which vector (exact-domain vs subdomain) — grounded in the single most-misunderstood distinction in email security: the envelope MAIL FROM that SPF authenticates vs the visible header From: that only DMARC governs. Explains precisely why SPF -all/~all alone is NOT spoof-proof without DMARC enforcement, and why SPF +all bypasses DMARC even under p=reject pct=100. Covers RFC 7208 §4.6.4's 10-DNS-lookup / 2-void-lookup PermError fail-open condition with a runnable stdlib-only lookup-counter script, plus the SPF-include-takeover supply-chain vector (an attacker re-registering a dead include inherits SPF-pass authority over the victim domain) with strict transient-vs-NXDOMAIN discrimination discipline so a temporary SERVFAIL is never mistaken for a takeover lead. Fully passive: DNS TXT reads only, no mail sent, no RCPT TO probe, no API keys. Use when auditing a domain's real spoofing resistance (not just its published records), explaining to a client why 'we have SPF -all' does not mean they're covered, investigating an SPF PermError or an unusually long include chain, evaluating a dead SPF include as a takeover lead, or writing a defensible spoofability finding for a deliverable.
日本語の概要は準備中です。原文の説明を表示しています。
elementalsouls/Claude-OSINT☆ 2,8132026年10月10日 更新
Turns one-shot external recon into a continuous monitoring program. Covers the scheduled re-scan-and-diff loop (baseline snapshot -> interval sleep -> re-scan -> asset/finding delta -> threshold-gated webhook alert), the scan-to-scan diff engine (new/removed/changed assets by a tracked-attribute table, new/resolved findings by a stable cross-scan fingerprint), adversary CTI / chatter monitoring across six public feeds (ransomwatch, ransomware.live, HackerNews Algolia search, Reddit security-subreddit RSS, GitHub Gist code-search, public Telegram channel scraping) with a source-kind-aware severity engine (leak-site/forum/telegram/paste tiers, CRITICAL through INFO), literal/glob/regex watchlist pattern matching, full-corpus capture with retroactive rescan on new watchlist entries, infrastructure-tracking-over-time discipline (certificate-transparency, passive-DNS, port/service, and typosquat re-enumeration cadence, and what a genuine 'perimeter drift' event looks like in the diff output), a five-state finding-lifecycle state machine (open/triaged/risk_accepted/resolved/false_positive) with per-severity SLA and fingerprint-based cross-scan dedup and auto-resolve/reopen rules, the alert-fatigue trap where a lifecycle-unaware rule re-fires on an already-accepted finding, a durable retry/backoff alert-outbox pattern ('queued is not delivered'), and copy-paste bash-cron plus PowerShell-Scheduled-Task recipes for a re-scan+diff loop with the Slack-compatible webhook payload shape. Passive OSINT and analysis only -- no new active-intrusion technique. Use when setting up ongoing monitoring for a retainer or MSSP engagement, tuning alert thresholds to avoid fatigue, triaging a finding's lifecycle status, investigating adversary chatter about a brand, building a 'what changed on the perimeter since last week' report, or deciding whether a persisting finding should re-alert.
日本語の概要は準備中です。原文の説明を表示しています。
elementalsouls/Claude-OSINT☆ 2,8132026年10月10日 更新
Pin the npm registry to the public default and fetch published release notes
日本語の概要は準備中です。原文の説明を表示しています。
cisco-ai-defense/skill-scanner☆ 2,5982026年10月14日 更新
Establish durable brand and voice context for cross-skill consumption. Generates BRAND.md (audience, positioning, do/don't editorial rules, taboo phrases, competitor differentiation) and VOICE.md (existing persona JSON re-expressed as readable prose), both written to the project root. When present, the blog orchestrator auto-loads these files for write, rewrite, brief, outline, calendar, and strategy workflows. Pairs with blog-persona, which manages the structured persona JSON. Use when user says "blog brand", "create brand context", "brand voice doc", "BRAND.md", "VOICE.md", "establish editorial brand", "brand guidelines for blog".
日本語の概要は準備中です。原文の説明を表示しています。
AgriciDaniel/claude-blog☆ 2,3832026年10月14日 更新
Establish durable brand and voice context for cross-skill consumption. Generates BRAND.md (audience, positioning, do/don't editorial rules, taboo phrases, competitor differentiation) and VOICE.md (existing persona JSON re-expressed as readable prose), both written to the project root. When present, the blog orchestrator loads these files, fenced as untrusted data, for write, rewrite, brief, outline, calendar, and strategy workflows. Pairs with blog-persona, which manages the structured persona JSON. Use when the user says "blog brand", "create brand context", "BRAND.md", "VOICE.md", "establish editorial brand". Not for learning a voice from existing posts (blog-style) or managing persona JSON (blog-persona).
日本語の概要は準備中です。原文の説明を表示しています。
AgriciDaniel/claude-blog☆ 2,3832026年10月14日 更新
Generate editorial calendars for blogs with topic clusters, publishing schedules, content decay detection, freshness update plans, seasonal opportunities, content mix formula, template integration, and distribution scheduling. Plans monthly or quarterly calendars optimized for SEO topic authority and freshness signals based on content priority. Use when user says "editorial calendar", "content calendar", "blog calendar", "publishing schedule", "blog plan", "content plan", "what should I write".
日本語の概要は準備中です。原文の説明を表示しています。
AgriciDaniel/claude-blog☆ 2,3832026年10月14日 更新
Writes, structures, and evaluates social posts end to end — hooks, body, formatting for how each platform renders, and a quality check before publishing. Use this to draft a post, rewrite one that underperformed, turn a longer piece into social content, sharpen an opening, or judge whether a draft is worth publishing.
日本語の概要は準備中です。原文の説明を表示しています。
cbrock84/headcount☆ 2,0542026年9月18日 更新
Structures the tax questions a growing business faces — corporate income, sales and use, payroll, nexus, and the obligations created by hiring or selling somewhere new. Use this to work out what a new state or country obligates you to, prepare for a tax filing or audit, understand sales tax on your product, or check what a remote hire or new market triggers.
日本語の概要は準備中です。原文の説明を表示しています。
cbrock84/headcount☆ 2,0542026年9月18日 更新
A low-level plotting library for comprehensive customization. Use when fine-grained control over every plot element is needed, creating new types of charts, or integrating into specific scientific workflows. Can export to PNG/PDF/SVG for publication. For quick statistical charts, use seaborn; for interactive charts, use plotly; for journal-style, publication-ready multi-panel charts, use scientific-visualization.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Use when interpreting scientific graphs and charts, explaining data visualizations for research presentations, writing figure captions for publications, or analyzing trends in clinical research data. Converts complex visual data into clear, accurate explanations for academic papers, clinical reports, and public presentations.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Use when formatting references for journal submission, converting between citation styles (APA, MLA, Vancouver, Chicago), generating bibliographies for manuscripts, or ensuring consistent reference formatting. Automatically formats citations and bibliographies in 1000+ academi...
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Generates complete single-compound network-toxicology research designs from one exposure, one disease or toxic phenotype, and a validation direction. Use when a study centers on one compound–one disease link and needs target collection, overlap construction, enrichment, PPI hub prioritization, docking, optional transcriptomic cross-check, and conservative mechanistic synthesis. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Generates complete process-related diagnostic biomarker bioinformatics research designs from a user-provided disease context, gene-family or pathway theme, and validation direction. Use when a study centers on process-related genes, DEG and WGCNA integration, machine-learning feature selection, nomogram-based diagnostic modeling, immune infiltration, regulatory-network analysis, and optional external or experimental validation. Covers five study patterns (process-DEG discovery, co-expression-module integration, machine-learning biomarker selection, diagnostic model/nomogram workflow, immune-regulatory interpretation and validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Generates complete programmed-cell-death (PCD) / regulated-cell-death (RCD) bulk-transcriptome oncology research designs from a user-provided disease and mechanism theme. Always use this skill whenever a user wants to design, plan, or structure a cancer bioinformatics study built around cell-death patterns, tumor microenvironment, prognostic modeling, immune landscape analysis, mutation profiling, and computational drug sensitivity. Covers five study patterns (mechanism-gene-set, subtype-discovery, prognostic-signature, immune-response stratification, translational drug-hypothesis) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, and a strictly verified reference literature retrieval layer with real references only.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Generates complete comparative network-toxicology research designs from a user-provided exposure pair, shared toxic phenotype, and validation direction. Use when a study centers on two related exposures under one outcome and needs target collection, shared-vs-specific target decomposition, enrichment, PPI hub prioritization, docking, optional transcriptomic cross-checks, and conservative mechanistic synthesis. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Generates complete tumor immune-infiltration-guided bulk-transcriptome diagnostic biomarker and machine-learning research designs from a user-provided cancer type and study direction. Always use this skill whenever a user wants to design, plan, or build a tumor bioinformatics study centered on differential expression, immune infiltration estimation, immune-linked module discovery, consensus feature selection, diagnostic modeling, nomogram construction, clinical association, and optional prognostic extension or validation. Covers five study patterns (immune-cell-first diagnostic workflow, immune-module-to-biomarker workflow, consensus-ML biomarker workflow, diagnostic-plus-prognostic hybrid workflow, translational validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, reference literature pack, and self-critical risk review.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Generates complete phenotype-scoring bioinformatics research designs for any disease context and any user-defined phenotype, pathway, process, signature, or molecular program. Use when a study centers on gene-set or feature-set definition, intersection with DEGs or candidate features, phenotype scoring, feature selection, diagnostic or stratification assessment, immune or cellular-resolution interpretation, network analysis, and optional orthogonal validation. Covers five study patterns (signature discovery, phenotype scoring, feature selection, immune/cellular interpretation, multi-layer validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Designs complete single-cell research plans from a user-provided biomedical direction. Always use this skill whenever a user wants to design, scope, or structure a single-cell study — including disease-focused, mechanism-focused, biomarker-focused, translational, perturbation-inspired, or validation-aware projects. It should define the research question, choose the best-fit study pattern, recommend sample grouping logic, suggest reference datasets as examples only, specify the core analysis modules, propose a validation ladder, and output four workload configurations (Lite / Standard / Advanced / Publication+). Never fabricate datasets, sample metadata, accession numbers, cohort availability, cell-type labels, external validation resources, or literature references. Always include the mandatory Dataset Disclaimer immediately before any workflow section that mentions datasets or public resources.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Generates complete NHANES-style cross-sectional epidemiology + retrospective clinical validation research designs from a user-provided disease and biomarker direction. Always use this skill whenever a user wants to design, plan, or build a population-level biomarker association study using NHANES or similar survey datasets, especially when the article logic includes disease definition, biomarker formula derivation, multivariable logistic regression, restricted cubic spline analysis, subgroup stability testing, and a secondary hospital-based retrospective validation cohort. Covers five study patterns (cross-sectional association, dose-response / RCS, subgroup-stability, NHANES + retrospective validation, preliminary screening-performance) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path...
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Designs complete research plans that integrate clinical variables with multi-omics data from a user-provided biomedical direction. Always use this skill whenever a user wants to design, scope, or structure a study that combines clinical variables with transcriptomics, proteomics, metabolomics, epigenomics, or related omics layers for mechanism interpretation, biomarker development, risk stratification, treatment-response analysis, or translational use. It should define the clinical use case, alignment across data layers, feature-reduction and fusion logic, modeling route, mechanism-interpretation layer, validation ladder, and four workload configurations (Lite / Standard / Advanced / Publication+). Never fabricate datasets, accession numbers, sample counts, metadata completeness, platform coverage, literature references, PMIDs, DOIs, or validation status. Always include the mandatory Dataset Disclaimer immediately before any workflow section that mentions datasets or public resources.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Generates complete conventional oncology bulk-transcriptome biomarker and hub-gene research designs from a user-provided cancer type and study direction. Always use this skill whenever a user wants to design, plan, or build a tumor bioinformatics study centered on differential expression, prognostic filtering or risk modeling, PPI-based hub-gene prioritization, diagnostic/prognostic evaluation, clinical association, immune infiltration context, methylation context, and optional tissue or cell validation. Covers five study patterns (signature-first prognostic workflow, hub-gene-first biomarker workflow, hybrid signature-to-hub workflow, immune-context biomarker workflow, translational validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path...
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Generates complete reference-grounded single-drug adverse-effect network-pharmacology research designs from a user-provided drug, adverse event, and desired evidence depth. Always use this skill when a user wants to design, plan, or upgrade a conventional network-pharmacology study centered on one fixed drug and one fixed adverse-effect endpoint, using drug-target prediction, adverse-event target collection, overlap analysis, PPI hub prioritization, enrichment interpretation, molecular docking, and optional orthogonal transcriptomic or literature validation. Covers five study patterns (canonical hub-first, cardiotoxicity or electrophysiology-oriented, immune-inflammatory adverse effect, organ-toxicity pathway context, translational validation) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with a recommended primary plan, dependency/evidence map, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, verified-reference pack, and self-critical risk review.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Generates complete reference-grounded single-drug adverse-effect network-pharmacology research designs from a user-provided drug, adverse event, and desired evidence depth. Always use this skill when a user wants to design, plan, or upgrade a conventional network-pharmacology study centered on one fixed drug and one fixed adverse-effect endpoint, using drug-target prediction, adverse-event target collection, overlap analysis, PPI hub prioritization, enrichment interpretation, molecular docking, and optional orthogonal transcriptomic or literature validation. Covers five study patterns (canonical hub-first, cardiotoxicity or electrophysiology-oriented, immune-inflammatory adverse effect, organ-toxicity pathway context, translational validation) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with a recommended primary plan, dependency/evidence map, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, verified-reference pack, and self-critical risk review.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新
Designs QTL colocalization studies that connect eQTL, pQTL, sQTL, or related molecular QTL signals with GWAS loci. Always use this skill whenever a user wants to plan, scope, or structure a locus-level study asking whether a GWAS association and a molecular QTL association may reflect the same underlying causal signal. Covers locus definition, QTL/GWAS source architecture, ancestry and LD alignment, single-locus vs multi-locus strategy, candidate-gene prioritization, optional fine-mapping, linked MR/SMR follow-up, and functional annotation. Always output four workload configurations (Lite / Standard / Advanced / Publication+) with a recommended primary plan, stepwise workflow, method rationale, evidence hierarchy, figure plan, minimal executable version, and strictly verified literature guidance with no fabricated references. Never equate colocalization with causality proof, mediation proof, or automatic target validation. Always include the mandatory Dataset Disclaimer immediately before any workflow section that mentions datasets, repositories, consortia, or public resources.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9512026年9月17日 更新